What is the duration of action of Humalog (insulin lispro) in a patient with diabetes?

Duration of Action of Humalog (Insulin Lispro)

Humalog has a duration of action of 3 to 4 hours in adult diabetic patients. 1

Pharmacokinetic Profile

The time-action characteristics of Humalog distinguish it as a rapid-acting insulin analog:

• Onset of action: 5 minutes 1
• Peak effect: 1 to 2 hours 1
• Duration of action: 3 to 4 hours 1

This pharmacokinetic profile represents a substantial difference from regular human insulin, which has a duration of action of 6 to 8 hours. 1 The American Diabetes Association confirms that rapid-acting analogs like lispro have a quicker onset and peak with a shorter duration of action compared to regular human insulin. 2

Clinical Implications

The shorter duration of action has important practical consequences for diabetes management:

• Timing flexibility: Humalog can be administered within 15 minutes before meals, compared to the 30-40 minute pre-meal timing required for regular insulin. 1

• Postprandial control: The time-action profile mimics the physiological response of endogenous insulin to food intake, providing effective control of postprandial glucose excursions. 3

• Reduced delayed hypoglycemia: The shorter duration minimizes the risk of hypoglycemia occurring hours after meals. 2

Critical Caveat

The short 3-4 hour action period means that without adequate basal insulin coverage, blood glucose levels can become unstable during gaps between rapid-acting insulin doses. 1 This is why Humalog is typically used in combination with longer-acting basal insulin (such as NPH, glargine, or degludec) to maintain glycemic control between meals and overnight. 2